Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 29, Issue 3-4, Pages 199-206
http://dx.doi.org/10.3233/DMA-2010-0733

Epidermodysplasia Verruciformis and Susceptibility to HPV

Tejas Patel,1 L. Katie Morrison,1,2 Peter Rady,1,2 and Stephen Tyring1,2

1Center for Clinical Studies, University of Texas Health Science Center, Houston, TX, USA
2Department of Dermatology, University of Texas Health Science Center, Houston, TX, USA

Received 14 December 2010; Accepted 14 December 2010

Copyright © 2010 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose of review: Epidermodysplasia verruciformis has been addressed in depth in the recent literature despite its rarity. The disease is characterized by a persistence in human papillomavirus infections and development of cutaneous malignancies, usually happening more frequently and at a younger age than in the general population. Because of the role of immunodeficiency to viral antigens eventually leading to cancer, EV has become a model for understanding a viral role in cutaneous oncogenesis. Susceptibility loci for EV have been mapped and encoded protein functions are becoming better understood. Discoveries of novel mutations and further study of EV-associated HPV serotypes in lesional and nonlesional skin of affected patients and the general population may help generate a cohesive theory regarding the true role of a defective immune barrier in oncogenesis.